Central Commission for Discipline Inspection: Cut off the chain of medical bribery benefits, crack down on kickbacks.

Pharmaceutical Network October 20, in recent years, Jiangsu Province through the "provincial organizations, alliance procurement, platform operation, results sharing" way, the formation of the province's sunshine procurement alliance, to play collective bargaining, joint bargaining, centralized procurement of the scale advantages of some products for high-value medical supplies to implement the alliance with volume procurement, price negotiations or medical insurance access negotiations, reduce the price of medical supplies, reduce the burden on patients.
July 31, Jiangsu Province, the third round of high-value medical supplies alliance with volume procurement negotiations.
Jiang Wei" holding the 'power' of purchasing drugs, pharmaceutical sales representatives are door-to-door visits, gift cards also followed..." Recently, the Central Commission for Discipline Inspection, the State Supervision Commission website of a video exposed the first people's hospital in Hangzhou, Zhejiang Province, the former pharmaceutical staff Wang Xiaojun used his position to facilitate, with others in the introduction of new drugs, drug procurement and other aspects for the benefit of drug dealers, illegal receipt of more than 10.19 million yuan in bribe details.
, only injection of sodium cephalosporine and other two drugs for Wang Xiaojun and others brought up to 3.25 million yuan of "benefits."
Case of Wang Xiaojun is not an example.
Reporters combed found that this year disclosed in the medical field corruption cases, the collection of drug supplies rebate problem appears the highest frequency, showing the high amount of money involved, corruption interests chain link and so on, resulting in high prices of drugs and medical supplies, medical costs too fast growth, a large number of loss of medical insurance funds and other issues, increase the burden of patients, infringe on the vital interests of the masses, it is urgent to fight.
2016-2019, more than half of the top 100 pharmaceutical companies in China have rebate problems Wang Xiaojun in the pharmaceutical procurement position for many years, very familiar with the procurement process.
At first, he mainly through the sale of doctor's prescription drug use statistics profit, tasted the sweetness, and then played a drug sales agent's abacion, and businessman Pan a certain should be outside, by Pan a certain operation in front of the stage, he is behind the scenes remote control command.
" Wang Xiaojun is responsible for the hospital's new drug introduction of the initial nuclear and daily procurement of drugs, grasping the hospital's drug information, his drug sales are not purely commercial behavior, but based on the convenience of the job.
," said the staff member of the County Commission for Discipline Inspection.
According to Wang Xiaojun, looking for drug standards, one is missing in the hospital, the other is the scope of application is relatively large, such as respiratory medicine, neurology, neurosurgery can be used, "the scope is large, sales are large, profits are high."
, Wang Xiaojun and Pan a two people will dozens of drugs "into" the county's first people's hospital, occupy a large market share.
drugmakers said Mr Wang charged rebates of up to 40 per cent of the drug's retail price.
" receipt of rebates on medicines and medical supplies is a common form of pharmaceutical bribery.
are explicit, such as cash transfers, and some are implicit, such as giving gifts, subsidizing travel, etc.
," Yu, deputy secretary of the Party Committee of the Sixth People's Hospital of Shanghai and secretary of the discipline committee, told reporters.
in addition to the huge amount involved in the case, corruption is increasingly hidden, in recent years, the investigation of medical bribery cases also show the characteristics of multi-participation.
A recent judgment published by the China Referee Papers Network shows that Chen Jianchang, former director of cardiovascular medicine at the Second Hospital affiliated with Suzhou University in Jiangsu Province, used his position to provide support and assistance for the sale, use and use of medical supplies by a number of companies, and received a total of 3.22 million yuan from the actual head of the above-mentioned company.
, Mr. Yan also paid bribes to other members of the department through Chen Jianchang, amounting to 2.79 million yuan.
"From 2010 to 2017, I went to the hospital every Year in January and February to find Chen Jianchang, Chen Jianchang will tell me in a few days to give him two money, one of which is for himself, the other is for him to the relevant personnel.
"a certain account.
not only to attack the "critical minority", but also to do a good point at all levels of the relevant personnel, drug supplies purchase and sale of the field of "grey competition", far more intense than imagined.
The State Health Insurance Administration price recruitment department responsible person said, according to the publicly accessible court judgment documents statistics, between 2016 and 2019, more than half of the country's hundred compulsory drug enterprises were found to have direct or indirect kickbacks, of which the most frequent enterprises involved in more than 20 cases in three years, a single case rebate amount of more than 20 million yuan.
drug bribery is prohibited, rebates how to become pharmaceutical companies knock on the door brick" rebate has become a pharmaceutical enterprises into the hospital knock brick.
" a pharmaceutical company practitioners told reporters that in the past drugs and supplies of the "life and kill power" by hospital staff control, and give rebates, it is in the fierce competition to win the top secret, "an enterprise sent, other enterprises should immediately follow up, slowly, we began to race for the relevant personnel to convey benefits, with them to do a good relationship, in exchange for drug sales and use of priority, and eventually form a vicious circle."
", such "transactions", not only give rise to overuse of drugs, over-examination, overuse of high-value medical supplies and other issues, but also high rebates through high drug prices passed on to patients, increasing their burden of medical treatment. "From the absolute price level, a considerable number of drug prices have long been falsely high moisture, some generic drug prices are more than 2 times higher than international prices, circulation costs accounted for the main part of the price," said the head of the joint procurement office for the centralized procurement and use of drugs organized by
.
" is difficult for many patients to accept.
, Anhui Province, said: "A few years ago to the hospital to see a doctor, a common cold on the prescription of hundreds of dollars of medicine, and finally I did not take the medicine, went straight away."
" Chongqing's Mr. Fu admitted: "These years the cost of seeing a doctor has actually been reduced, but before exposed too much to get rebates, a high price of drugs, or can not help but think, there is nothing in this 'cat tired'."
" medical bribery is so difficult to eradicate? Several industry experts say the concentration of power and the lack of effective regulation are the most immediate reasons.
in the previous pharmaceutical circulation chain, hospital departments are the "only way" from production to access to pharmacies, the relevant staff have absolute say.
still take the case of Wang Xiaojun as an example, according to its account, because it is itself an "administrator", has the highest authority, want to sell doctors prescription drug use statistics to profit will certainly be able to do.
", if the supervision, in fact, there is a corresponding alarm system, but the administrator himself can turn off the system.
" a person in the industry also said: "the key posts and key links of integrity risk prevention and control attention is not enough, supervision flow in the form, is the general disease of the medical system."
", the previous "recruitment and separation" of drug procurement model, but also caused by the prohibition of pharmaceutical bribery is one of the reasons.
2006, the National Development and Reform Commission issued the Opinions on Further Rectifying the Market Price Order of Medicines and Medical Services, which stipulates that medical institutions at or above the county level can charge a 15% increase in the rate of drug sales.
with the deepening of the reform of the medical and health system, the drug increase has now been completely abolished.
Although the retail discount rate of drugs is strictly limited, but because of the decentralized procurement model there is only the problem of price without volume, volume price decoupling, enterprises lack sales expectations, in order to obtain higher returns, often take the initiative to pay bribes to the hospital, the winning bid will be high.
seven kinds of unconscionability into the blacklist, bribery drug companies will lose access to the market" pharmaceutical bribery frequently appeared, the fundamental crux is that the industry ecology has been distorted.
" said that, on the one hand, some medical system cadres care about party discipline and state law and professional ethics, willing to form an interest alliance with pharmaceutical companies, and some even in the investigation to "receiving kickbacks is the rules of the medical industry" as a reason to justify themselves, reflecting the loose line of thought.
On the other hand, while bribery and bribery are two "poison melons" that have been found on a vine, it is often the briber who accepts the law when it comes to investigating cases of medical corruption, and the price paid by the briber is almost negligible.
compared with the huge benefits of bribery, its low "cost" so that many pharmaceutical companies in the East Window incident is still my own, repeated bribery, while paying bribes to many people from time to time.
" bribery not only corrupts the cadre, but also seriously undermines fair competition in the market.
to investigate the bribery side, the briber can not be easily let go.
," said the person in charge of the policy and regulation office of the Hunan Provincial Commission for Discipline Inspection.
Reporters noted that the State Health Insurance Administration recently issued "on the establishment of pharmaceutical prices and credit evaluation system guidance", requiring all regions by the end of 2020 to establish and implement the credit evaluation system, involving pharmaceutical commercial bribery and other 7 kinds of unconlianced pharmaceutical enterprises will be included in the "black list" of disrelieving.
Ding Wei, deputy party secretary and secretary of the discipline committee at Beijing Children's Hospital, said the innovation of the National Health Insurance Administration in promoting the establishment of a credit evaluation system was to step up efforts to crack down on bribery.
In the 2020 edition of the list of pharmaceutical prices and the list of matters of mis-credit, "in the purchase and sale of medicines, to all kinds of medical institutions at all levels, centralized procurement agencies and their staff rebates or other improper benefits" ranked first in the main cases of mis-trust.
Pharmaceutical enterprises will face written reminders and warnings, relying on centralized procurement platform to remind buyers of risk information, limit or suspend the relevant drugs or medical supplies hanging on the network, limit or suspend the procurement of related drugs or medical supplies, disclosure of disincance information and other disposal measures, misinrepishment involving the number of provinces to meet the prescribed conditions, will also be initiated by the State Health Insurance Administration pharmaceutical prices and tender procurement guidance center national joint disposal.
establish a medical price and credit evaluation system, can solve the traditional governance system to a certain extent, the responsibility is difficult to collect, difficult to deal with the problem.
" National Health Insurance Bureau price recruitment department responsible person said, "pharmaceutical enterprises are often insensitive to rebate cases of fines, but to give rebates will lead to the loss of access to the centralized procurement market, will have a strong deterrent effect, resulting in a system of governance effect."
"adhere to comprehensive policy, systematic governance, explore the establishment of multi-sectoral exchanges and policy linkage mechanism" 'blacklist' in the past to delineate the price and marketing red line, express the risk of loss of trust, pull up the live high-voltage line, from the point of view of combating bribery is of great significance.
" Ding said that this measure warned the relevant pharmaceutical enterprises to pay attention to the construction of connotation, accelerate the transformation, and give rebates and other improper prices and marketing behavior thoroughly cut, conducive to the creation of a clean health care industry ecological environment.
Reporters noted that after the "black list" system of pharmaceutical companies came out, in order to ensure timely and accurate and complete access to the source of the case information, the State Health Insurance Administration actively promote cooperation with the judiciary, taxation, market supervision and other departments to explore the establishment of exchanges and policy linkage mechanism.
Recently, the Supreme People's Court and the State Health Insurance Administration signed the Memorandum of Cooperation on the Exchange and Sharing of Information on Commercial Bribery Cases in the Pharmaceutical Field, established a regular notification system for commercial bribery cases in the pharmaceutical field, and continuously deepened cooperation in the management of commercial bribery in the pharmaceutical field.
" is necessary to establish a cooperative mechanism and regular notification system, which will help to break down information barriers between departments, promote information exchange and sharing at all levels of the system, and enhance the accuracy and authority of the 'blacklist'.
" said, "In order to better play the 'blacklist' effect, we should also pay close attention to the implementation of the system, to the provincial drug and medical supplies responsible for the implementation of centralized procurement agencies to organize more and more specific guidance to promote the formation of a normal mechanism."
" National Health Insurance Bureau price recruitment department responsible person said that the root of the problem of pharmaceutical rebates, we must adhere to the system of governance, governance according to law, comprehensive governance, source governance, multi-sector linkage, comprehensive policy, to build pharmaceutical enterprises "dare, can not, do not want" to give rebates of the governance system, "from the reform level to continue to work hard to comprehensively We will deepen the reform of the centralized procurement system for pharmaceutical supplies with the goal of centralized procurement, consolidate and improve the procurement rules and policy system, realize normal operation, improve the budget management and quantitative assessment of the total amount of medical insurance funds, implement multi-composite payment methods such as payment by disease type and by disease diagnosis-related sub-groups, and promote public hospitals to strengthen cost awareness and cooperate with the reduction of the purchase price of drug supplies.
" orderly promotion of medical service price reform, cut off drug supplies rebate interest chain reporter comb found that, in addition to the establishment of pharmaceutical credit evaluation system, the recent medical field there is a series of "big action."
September 14, the state organized the central procurement and use of high-value medical supplies start-up meeting held in Tianjin, marking that after the centralized procurement of drugs, high-value medical supplies represented by the crown stent will also fully enter the era of belt procurement. Chen Jinfu, deputy director of the State Health Insurance Administration, said:
Resuming the impact of the original sales model on the development of China's industry, and truly through cost competition, quality competition, innovation, to promote scale development, advantage development."
the end of September, the State Health and Welfare Commission, together with relevant departments, organized comprehensive supervision and inspection of the medical and health industry, and conducted field inspections of 19 provinces (regions, cities) such as Beijing and Hebei, as well as the Xinjiang Production and Construction Corps.
inspection team mainly solicits five aspects of the drug field commercial bribery and other clues, which are representative of the problem clues, in the field inspection to carry out spot checks and verification, timely response to social concerns.
"volume procurement, disrelition 'blacklist', field inspectors ... This combination of punches demonstrates the determination of the Party and the government to practice the concept of 'people first, life first', rectify the chaos in the medical and health industry, and earnestly safeguard the interests of the people.
" Ding said that with a series of regulatory policies have landed, the traditional drug marketing methods will be remodeled, for pharmaceutical companies, only compliance, quality to win, is the ultimate way out.
In order to completely cut off the drug supplies rebate interest chain, the State Health Insurance Administration will also steadily and orderly promote the reform of medical service prices, through the regulation of the overall level of medical services prices, straighten out the price relationship, so that public hospitals more through medical income to obtain reasonable compensation, reduce the use of pharmaceutical supplies in the gray interests of dependence.
healthy China can not be separated from the protection of a good medical environment.
" said that in addition to improving the system, plug loopholes, industry authorities and discipline inspection and supervision organs should also adhere to the pass forward, strengthen the medical system related personnel's ideological education, in-depth integrity education, guide them to build a solid ideological defense line;